YingZhao Ph.D.

Associate

Silicon Valley + 1.650.739.3980

Dr. Ying Zhao's practice focuses on intellectual property matters, including counseling clients with respect to technology licensing and commercial transactions and patent procurement in various countries and jurisdictions.

Ying leverages her background in genetics and biomedical engineering, and her graduate research focused on the mechanisms of emergence of gene copy-number variations and DNA damage repair. She also has research experience in biomedical engineering, including methods for efficient gene synthesis, computational protein design, and tissue engineering.

Experience

  • Astellas Pharma to acquire iota BiosciencesJones Day is advising Astellas Pharma Inc. in its acquisition of iota Biosciences.
  • DataBank to acquire zColoJones Day is advising DataBank, a leading provider of enterprise-class colocation, connectivity, and managed services, on its acquisition of zColo, including certain U.S. and European data center assets, from Zayo Group Holdings, Inc.
  • Synaptics divests LCD TDDI business to Hua Capital for $139.4 millionJones Day advised Synaptics Incorporated in its $139.4 million divestiture of its Asia-based mobile LCD TDDI Business to an affiliate of Hua Capital.
  • Hitachi Vantara acquires Waterline Data, Inc.Jones Day advised Hitachi Vantara LLC, a wholly owned subsidiary of Hitachi, Ltd., in its acquisition of all of the assets of Waterline Data, Inc., a U.S.-based company that provides intelligent data cataloging solutions for DataOps that help customers more easily gain actionable insights from large datasets and comply with data regulations.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.